The Clinical Pharmacology of Elotuzumab
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Pharmacokinetics"
DOI: 10.1007/s40262-017-0585-6
Abstract: Novel treatment options are needed to improve long-term outcomes for patients with multiple myeloma (MM). In this article, we comprehensively review the clinical pharmacology of elotuzumab, a first-in-class monoclonal anti-SLAMF7 antibody approved in combination with… read more here.
Keywords: exposure; pharmacology; clinical pharmacology; elotuzumab ... See more keywords